Related references
Note: Only part of the references are listed.Zwitterionic Nanocages Overcome the Efficacy Loss of Biologic Drugs
Bowen Li et al.
ADVANCED MATERIALS (2018)
Polypeptides with High Zwitterion Density for Safe and Effective Therapeutics
Peng Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes
Taro Shimizu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens
Hidenori Ando et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
Barry W. Neun et al.
MOLECULES (2018)
Evaluating the Accelerated Blood Clearance Phenomenon of PEGylated Nanoemulsions in Rats by Intraperitoneal Administration
Yuqing Su et al.
AAPS PHARMSCITECH (2018)
Antibody-Antigen Interaction Dynamics Revealed by Analysis of Single-Molecule Equilibrium Fluctuations on Individual Plasmonic Nanoparticle Biosensors
Srdjan S. Acimovic et al.
ACS NANO (2018)
Enhanced Opsonization-Independent Phagocytosis and High Response Ability to Opsonized Antigen-Antibody Complexes: A New Role of Kupffer Cells in the Accelerated Blood Clearance Phenomenon upon Repeated Injection of PEGylated Emulsions
Xiaobo Cheng et al.
MOLECULAR PHARMACEUTICS (2018)
A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics
Taro Shimizu et al.
PHARMACEUTICAL RESEARCH (2018)
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
Fangfang Chen et al.
NATURE NANOTECHNOLOGY (2017)
A brush-polymer/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly(ethylene glycol) antigenicity
Yizhi Qi et al.
NATURE BIOMEDICAL ENGINEERING (2017)
Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
Yu Mima et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Complement activation turnover on surfaces of nanoparticles
S. M. Moghimi et al.
NANO TODAY (2017)
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone
Justin McCallen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Nanoparticle interactions with the immune system: clinical implications for Liposome-Based cancer chemotherapy
Ninh M. La-Beck et al.
FRONTIERS IN IMMUNOLOGY (2017)
Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone
Justin McCallen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2017)
Sensitive and Quantitative Detection of Anti-Poly(ethylene glycol) (PEG) Antibodies by Methoxy-PEG-Coated Surface Plasmon Resonance Sensors
Peng Zhang et al.
ANALYTICAL CHEMISTRY (2017)
Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules
Wen-Wei Lin et al.
ANALYTICAL CHEMISTRY (2017)
Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
Nancy J. Ganson et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance
Kouichi Shiraishi et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
Peter L. Turecek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Christian Lubich et al.
PHARMACEUTICAL RESEARCH (2016)
Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle Technology
Huijin Dong et al.
AAPS JOURNAL (2015)
Protein-polymer conjugation - moving beyond PEGylation
Yizhi Qi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
Taro Shimizu et al.
IMMUNOBIOLOGY (2015)
Determination of polymeric micelles' structural characteristics, and effect of the characteristics on pharmacokinetic behaviors
Kouichi Shiraishi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity
Peng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PEGylated Biopharmaceuticals: Current Experience and Considerations for Nonclinical Development
Inge A. Ivens et al.
TOXICOLOGIC PATHOLOGY (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Modulation of Complement Activation and Amplification on Nanoparticle Surfaces by Glycopolymer Conformation and Chemistry
Kai Yu et al.
ACS NANO (2014)
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Johan J. F. Verhoef et al.
DRUG DISCOVERY TODAY (2014)
Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth
S. M. Moghimi
JOURNAL OF CONTROLLED RELEASE (2014)
Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial
Nicola Longo et al.
LANCET (2014)
Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins
Mark G. P. Saifer et al.
MOLECULAR IMMUNOLOGY (2014)
Evading Immune Cell Uptake and Clearance Requires PEG Grafting at Densities Substantially Exceeding the Minimum for Brush Conformation
Qi Yang et al.
MOLECULAR PHARMACEUTICS (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Peter E. Lipsky et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Single-Walled Carbon Nanotube Surface Control of Complement Recognition and Activation
Alina J. Andersen et al.
ACS NANO (2013)
Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration
Amr S. Abu Lila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Complement monitoring of Pluronic 127 gel and micelles: Suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100
Islam Hamad et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon
Kouichi Shiraishi et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Huub Schellekens et al.
PHARMACEUTICAL RESEARCH (2013)
Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates
Merry R. Sherman et al.
BIOCONJUGATE CHEMISTRY (2012)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Composition Dependence of the Micellar Architecture Made from Poly(ethylene glycol)-block-Poly(partially benzyl-esterified aspartic acid)
Yusuke Sanada et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2012)
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Carl D. Walkey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics
Jillian L. Perry et al.
NANO LETTERS (2012)
Material properties in complement activation
S. Moein Moghimi et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Distinct Polymer Architecture Mediates Switching of Complement Activation Pathways at the Nanosphere-Serum Interface: Implications for Stealth Nanoparticle Engineering
Islam Hamad et al.
ACS NANO (2010)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers
Tsutomu Ishihara et al.
BIOMACROMOLECULES (2010)
Polymeric micelles as a new drug carrier system and their required considerations for clinical trials
Masayuki Yokoyama
EXPERT OPINION ON DRUG DELIVERY (2010)
T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes
Hiroyuki Koide et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: The challenges ahead
S. M. Moghimi et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Accelerated Blood Clearance Was Not Induced for a Gadolinium-Containing PEG-poly(L-lysine)-Based Polymeric Micelle in Mice
Huili Ma et al.
PHARMACEUTICAL RESEARCH (2010)
Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats
Masako Ichihara et al.
Pharmaceutics (2010)
Emerging PEGylated drugs
Jung Seok Kang et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control
Taku Satoh et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Histological study on side effects and tumor targeting of a block copolymer micelle on rats
Takanori Kawaguchi et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents
Kouichi Shiraishi et al.
JOURNAL OF CONTROLLED RELEASE (2009)
An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin
Alberto Gabizon et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Anti-tumor effect of all-trans retinoic acid loaded polymeric micelles in solid tumor bearing mice
Narin Chansri et al.
PHARMACEUTICAL RESEARCH (2008)
What are determining factors for micelle carriers? Consideration stable drug incorporation into polymeric on physical and chemical characters of the micelle inner core
Tatsuhiro Yamamoto et al.
JOURNAL OF CONTROLLED RELEASE (2007)
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Pharmacokinetics of poly(hydroxyethyl-L-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration
Birgit Romberg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production
S. Moein Moghimi et al.
FASEB JOURNAL (2006)
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles
Kumi Kawano et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
NJ Ganson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions
A Chanan-Khan et al.
ANNALS OF ONCOLOGY (2003)
Share Paper
